| | 
Part, Chapter, Paragraph
1 I, 2. 6 | funded education is close to 100 for basic and upper-secondary
2 I, 2. 10. 2| dimensions range between 1 and 100 nm (0.001-0.1 μm), are characterized
3 I, 2. 10. 2| Nanorods: nanoparticles with 1- 100 nm length, used in medicine
4 I, 2. 10. 2| Iron-oxide nanoparticles (5-100 nm range) are used for selective
5 I, 3. 3 | available, for the past 50 or 100 years or so. The issue is
6 I, 3. 3 | depict persons of 0 to about 100 years of age, these pyramids
7 I, 3. 3 | of a country in the past 100 years. In addition to population
8 II, 5. 2. 3| vary from 42.7 deaths per 100.000 in France to 327.0 deaths
9 II, 5. 2. 3| France to 327.0 deaths per 100.000 in Latvia, being there
10 II, 5. 2. 3| higher (in men 72 deaths per 100.000 in France and 555 in
11 II, 5. 2. 3| Latvia; in women 16 per 100.000 in France and 167 in
12 II, 5. 2. 3| population) mortality rates per 100.000.~ ~Mortality trends
13 II, 5. 2. 3| countries2 (from 300 to 186 per 100.000), 45% in Central Eastern
14 II, 5. 2. 3| countries3 (from 440 to 242 per 100.000), 27% in Eastern Europe
15 II, 5. 2. 3| countries4 (from 450 to 326 per 100.000), 37% in Central Europe
16 II, 5. 2. 3| countries5 (from 225 to 142 per 100.000), 34% in Southern Europe
17 II, 5. 2. 3| countries6 (from 139 to 91 per 100.000) and 27% in Baltic7
18 II, 5. 2. 3| countries (from 696 to 505 per 100.000). Similar results can
19 II, 5. 2. 3| countries (from 73 to 44 per 100.000), 51% in Central Eastern
20 II, 5. 2. 3| countries (from 157 to 77 per 100.000), 23% in Eastern Europe
21 II, 5. 2. 3| countries (from 169 to 130 per 100.000), 41% in Northern Europe (
22 II, 5. 2. 3| Europe (from 102 to 61 per 100.000), 36% in Baltic Europe
23 II, 5. 2. 3| countries (from 231 to 148 per 100.000) and 41% in Southern
24 II, 5. 2. 3| countries (from 40 to 23 per 100.000).~ ~Figure 5.2.1. Age-standardized
25 II, 5. 2. 3| Age-standardized mortality rates per 100.000. Trends for ischemic
26 II, 5. 2. 3| Age-standardized mortality rates per 100.000. Trends for ischemic
27 II, 5. 2. 3| and recurrent events) per 100.000 during 10-year registration
28 II, 5. 2. 3| cerebrovascular mortality rates per 100.000 men and women aged 35-
29 II, 5. 2. 3| varies from 60 deaths per 100.000 in France to 399 deaths
30 II, 5. 2. 3| France to 399 deaths per 100.000 in Romania, being there
31 II, 5. 2. 3| varies from 36 deaths per 100.000 in France to 297 deaths
32 II, 5. 2. 3| Europe (from 133 to 49 per 100.000), 40% in Southern Europe
33 II, 5. 2. 3| countries (from 136 to 82 per 100.000), 21% in Northern countries (
34 II, 5. 2. 3| countries (from 110 to 87 per 100.000), 34% in Central Eastern
35 II, 5. 2. 3| Europe (from 273 to 180 per 100.000) and 6% in Baltic Europe
36 II, 5. 2. 3| countries (from 298 to 279 per 100.000). Mortality increased
37 II, 5. 2. 3| Europe (from 324 to 357 per 100.000). In 2003, mortality
38 II, 5. 2. 3| population) mortality rates per 100.000 Cerebrovascular disease (
39 II, 5. 2. 3| Europe (from 89 to 54 per 100.000), 46% in Southern Europe
40 II, 5. 2. 3| countries (from 99 to 54 per 100.000), 21% in Northern countries (
41 II, 5. 2. 3| countries (from 87 to 68 per 100.000), 13% in Baltic Europe
42 II, 5. 2. 3| countries (from 218 to 189 per 100.000) and 37% in Central
43 II, 5. 2. 3| Europe (from 193 to 121 per 100.000). Mortality rates increased
44 II, 5. 2. 3| Europe (from 203 to 246 per 100.000). In 2003, mortality
45 II, 5. 2. 3| population) mortality rates per 100.000 Cerebrovascular disease (
46 II, 5. 2. 3| fatal and non fatal) per 100.000 mean of the last 3 years
47 II, 5. 3. 1| demonstrated by the fact that about 100 cancer sites are considered
48 II, 5. 3. 1| of new cancer cases per 100,000 population at risk;~ ~-
49 II, 5. 3. 1| of deaths for cancer per 100,000 population at risk;~ ~-
50 II, 5. 3. 3| from registry database with 100% coverage). The estimates
51 II, 5. 3. 5| for men (599 new cases per 100,000) and in Denmark for
52 II, 5. 3. 5| women (414 new cases per 100,000). Maximum mortality
53 II, 5. 3. 5| for men (364 deaths per 100,000) and in Denmark for
54 II, 5. 3. 5| for women (196 deaths per 100,000). The highest incidence
55 II, 5. 3. 5| for men (482 new cases per 100,000, Figure 5.3.2a) and
56 II, 5. 3. 5| women (351 new cases per 100,000, Figure 5.3.2b), while
57 II, 5. 3. 5| for men (287 deaths per 100,000, Figure 5.3.4a) and
58 II, 5. 3. 5| for women (155 deaths per 100,000, Figure 5.3.4b).~Figures
59 II, 5. 3. 5| for men (37 new cases per 100,000) and in Lithuania for
60 II, 5. 3. 5| women (18 new cases per 100,000); while maximum levels
61 II, 5. 3. 5| Lithuania for men (29 deaths per 100,000) and in Estonia for
62 II, 5. 3. 5| for women (12 deaths per 100,000). Incidence and mortality
63 II, 5. 3. 5| for men (106 new cases per 100,000) and Switzerland for
64 II, 5. 3. 5| women (56 new cases per 100,000). Finland had lower
65 II, 5. 3. 5| men and 41 new cases per 100,000 in women). Figures 5.
66 II, 5. 3. 5| men (over 40 deaths per 100,000) and for women (over
67 II, 5. 3. 5| women (over 24 deaths per 100,000).~Colorectal cancer
68 II, 5. 3. 5| cases and 110 deaths per 100,000) against Sweden with
69 II, 5. 3. 5| cases and 29 deaths per 100,000). Sweden had a lower
70 II, 5. 3. 5| 46 vs 41 new cases per 100,000). Eastern Europe had
71 II, 5. 3. 5| cases and 85 deaths per 100,000). While Northern Europe
72 II, 5. 3. 5| cases and 27 deaths per 100,000 in 2006).~Most European
73 II, 5. 3. 5| Belgium (138 new cases per 100,000). Breast cancer incidence
74 II, 5. 3. 5| Iceland) to 34 deaths per 100,000 (in Denmark). Mortality
75 II, 5. 4. 2| of Type 1 diabetes by age/100,000 population 0–14 years~
76 II, 5. 4. 2| death diabetes mellitus/100,000 general population~12~
77 II, 5. 4. 2| population from all causes /100,000 general population,
78 II, 5. 4. 2| children in one year per 100.000 children.~Prevalence
79 II, 5. 4. 2| age, with values all over 100/1000 for EUCID participating
80 II, 5. 4. 2| replacement therapy) per 100,000 individuals in the diabetic
81 II, 5. 4. 2| dialysis/transplantation per 100.000 diabetic population
82 II, 5. 4. 2| dialysis/transplantation per 100,000 individuals in the diabetic
83 II, 5. 4. 2| death diabetes mellitus/100,000 general population.
84 II, 5. 4. 2| medical) in diabetic patients /100,000 general population~9~
85 II, 5. 4. 2| stroke in diabetic patients /100,000 general population~10~
86 II, 5. 4. 2| infarction in diabetic patients/100,000 general population~10~ ~
87 II, 5. 4. 2| amputations (above ankle) per 100,000 individuals in the diabetic
88 II, 5. 4. 2| ischemic and bleeding) per 100,000 individuals in the diabetic
89 II, 5. 4. 2| myocardial infarction per 100,000 individuals in the diabetic
90 II, 5. 4. 3| and 60 (Finland) cases per 100,000 per year. The median
91 II, 5. 4. 3| Cyprus) to 149 (Scotland) per 100,000, with a median of 79 (
92 II, 5. 4. 3| dialysis/transplantation per 100.000 diabetic population.
93 II, 5. 4. 3| with a median of 304 every 100,000 diabetics, corresponding
94 II, 5. 4. 3| and 199 (Portugal) per 100,000 in 10 countries delivering
95 II, 5. 4. 3| The median value is 31/100,000, corresponding to France.
96 II, 5. 4. 3| between 32% (Finland) and 100% (Cyprus).~Level of blood
97 II, 5. 4. 3| Scotland) to 574 (Spain) per 100,000 diabetes patients, with
98 II, 5. 4. 3| with a median of 669 per 100,000. There is a clear influence
99 II, 5. 4. 4| average, a town of Europe with 100 000 inhabitants would loose
100 II, 5. 4. 6| gold standard to achieve is 100%. Thus, the dissemination
101 II, 5. 4. 8| and Metabolism 2001;14(2), 100-103.~Carinci M, Federici
102 II, 5. 5. 1| mental disorders as total per 100 000 population for newly
103 II, 5. 5. 1| self-inflicted injury per 100 000 population. Age standardisation
104 II, 5. 5. 1| intentional self-harm per 100 000 whole population (standardized
105 II, 5. 5. 1| inflicted accidents per 100 000 people by country and
106 II, 5. 5. 1| inflicted accidents (per 100 000 people) by gender in
107 II, 5. 5. 1| inflicted accidents (per 100 000) in Europe.~ ~The changes
108 II, 5. 5. 1| at global level, 70 per 100 000 and Lithuanian women
109 II, 5. 5. 1| in the world with 14 per 100 000 (WHO statistics).~ ~
110 II, 5. 5. 3| that bulimia affects 30 per 100.000 females, whereby the
111 II, 5. 5. 3| incidence rate of 81,1 per 100.000 (Hoek and van Hoeken,
112 II, 5. 5. 3| Worldwide, between 16 and 42 per 100 000 population experience
113 II, 5. 5. 3| crude F20-death rates per 100 000 inhabitants would allow
114 II, 5. 5. 3| about 20.506 is more than 100 fold higher than the value
115 II, 5. 5. 3| psychologists from 0.1 to 96 per 100 000 population (WHO, 2005c).
116 II, 5. 5. 3| ranges from 44 to 73 per 100,000, while the incidence
117 II, 5. 5. 3| ranges from 24 to 57 per 100,000 (Forsgren et al, 2005;
118 II, 5. 5. 3| 5.3.4.2. Incidence (per 100,000) of epilepsy in Europe,
119 II, 5. 5. 3| cases (incidence 23.5 per 100,000 per year). Undetermined
120 II, 5. 5. 3| occurred in 15% (8.7 per 100,000 per year), cryptogenic
121 II, 5. 5. 3| epilepsy in 16% (8.8 per 100,000 per year), symptomatic
122 II, 5. 5. 3| epilepsy in 15% (8.4 per 100,000 per year), and idiopathic
123 II, 5. 5. 3| epilepsy in 6% (3.4 per 100,000 per year). In Bordeaux,
124 II, 5. 5. 3| lower. The rate was 15.3 per 100,000 for localization-related
125 II, 5. 5. 3| symptomatic 13.6), 6.7 per 100,000 for generalized epilepsies (
126 II, 5. 5. 3| symptomatic 1.1) and 1.9 per 100,000 for undetermined epilepsies (
127 II, 5. 5. 3| epilepsy ranges from 1 to 8 per 100,000 population per year,
128 II, 5. 5. 3| mortality rates at 1-2 per 100,000 (Massey et al, 1985).~
129 II, 5. 5. 3| investigating mortality in the past 100 years, the SMR for epilepsy
130 II, 5. 5. 3| 5.3.5.2. Prevalence (per 100 000) of Multiple Sclerosis
131 II, 5. 5. 3| 5.3.5.3. Prevalence (per 100 000) of Multiple Sclerosis
132 II, 5. 5. 3| 5.3.5.4. Incidence (per 100 000/year) of Multiple Sclerosis
133 II, 5. 5. 3| significantly from 3 to 6 per 100 000 per year in the western
134 II, 5. 5. 3| prevalence in France is 65 per 100 000 (Vukusic et al, 2007),
135 II, 5. 5. 3| Prevalence of 39 and 21 per 100 000 has been reported for
136 II, 5. 5. 3| from approx. 20 to 190 per 100 000. Mean rates are higher
137 II, 5. 5. 3| ranges between 11 and 282 per 100 000 in women and between
138 II, 5. 5. 3| and between 10 and 123 per 100 000 in men, with female:
139 II, 5. 5. 3| is estimated to be 4 per 100 000, with peaks registered
140 II, 5. 5. 3| ranging from 0.6 to 1.0 per 100 000 as reported by WHO for
141 II, 5. 5. 3| However, rates up to 3.6 per 100 000 are reported in the
142 II, 5. 5. 3| 5.3.5.7. Mortality (per 100 000) of MS patients in selected
143 II, 5. 5. 3| prevalence (MSA:1.86 to 4.9/100.000, PSP: 2.5 to 7.5/100.
144 II, 5. 5. 3| 100.000, PSP: 2.5 to 7.5/100.000; CGD: 4.0/100.000, respectively (
145 II, 5. 5. 3| to 7.5/100.000; CGD: 4.0/100.000, respectively (Nath
146 II, 5. 5. 3| older age groups (>85y; 2205/100.000), however, approximately
147 II, 5. 5. 3| estimates varied from 5/100,000 to 346/100,000. The
148 II, 5. 5. 3| varied from 5/100,000 to 346/100,000. The latter estimate
149 II, 5. 5. 3| considerably, from 65.6/100,000 in Sardinia (Rosati
150 II, 5. 5. 3| Rosati et al, 1980) to 12,500/100,000 for institutionalised
151 II, 5. 5. 3| approximately 120 to 257/100,000 and 11 to 19/100,000
152 II, 5. 5. 3| 257/100,000 and 11 to 19/100,000 per year, respectively.
153 II, 5. 5. 3| much higher: 1,280 to 1,500/100,000 and 346/100,000, respectively.
154 II, 5. 5. 3| to 1,500/100,000 and 346/100,000, respectively. The large
155 II, 5. 5. 3| in rates (65.6 to 12,500/100,000) may be the consequence
156 II, 5. 5. 3| highest prevalence of 12,500/100,000 was obtained from a
157 II, 5. 5. 3| Europe range from 5 per 100,000 to 26 per 100,000, according
158 II, 5. 5. 3| 5 per 100,000 to 26 per 100,000, according to the identified
159 II, 5. 5. 3| incidence rate of 326 per 100,000 for people aged 65-84 (
160 II, 5. 5. 3| clinico-pathological study of 100 cases. Journal of neurology,
161 II, 5. 6. 3| 50 and 140 procedures / 100,000 (Merx et al, 2003).
162 II, 5. 6. 3| of RA range from 4–13 per 100,000 for adult males and
163 II, 5. 6. 3| adult males and 13-36 per 100,000 for adult females. Estimates
164 II, 5. 6. 3| with age, with rates of 2/100,000 person-years in women
165 II, 5. 6. 3| under 35,rising to 3032/100,000 person-years in women
166 II, 5. 7. 1| patients with ESRD have a 100 times higher risk (Baigent
167 II, 5. 7. 5| Health established a list of 100 public health objectives;
168 II, 5. 8. 3| 41 300 lost work days per 100 000 population are due to
169 II, 5. 8. 7| Studies. Respir Med 2006; 100: 264-272.~ ~Lindberg A,
170 II, 5. 8. 7| population. Respir Med 2006; 100: 1973-1980.~ ~Mohangoo AD,
171 II, 5. 8. 7| with COPD. Respir Med 2006; 100: 1349-1355.~ ~Viegi G, Pedreschi
172 II, 5. 9. 3| Standardized Death Rates (per 100,000 people) in all EU Countries
173 II, 5. 11. 3| is likely not to protect 100% of sensitized people from
174 II, 5. 11. 3| disease that affects 85-100% of people at some time
175 II, 5. 11. 3| new cases of melanoma per 100,000. Many cancer registries
176 II, 5. 11. 3| skinned population (per 100 000).~ ~ ~There is little
177 II, 5. 11. 3| incidence rate of 88 per 100 000 for BCC, of 29 per 100
178 II, 5. 11. 3| 100 000 for BCC, of 29 per 100 000 for SCC and 14 per 100
179 II, 5. 11. 3| 100 000 for SCC and 14 per 100 000 for melanoma (de Rijke
180 II, 5. 12. 1| mortality rates (around 30-40/100,000 men and 10-16/100,000
181 II, 5. 12. 1| 40/100,000 men and 10-16/100,000 women) in Europe were
182 II, 5. 12. 1| the lowest ones (below 10/100,000 men and 5/100,000 women)
183 II, 5. 12. 1| below 10/100,000 men and 5/100,000 women) were registered
184 II, 5. 12. 1| Europe reaching rates over 58/100,000 men and 22/100,000 women
185 II, 5. 12. 1| over 58/100,000 men and 22/100,000 women in Hungary in
186 II, 5. 12. 2| Age-standardized rates per 100,000 population, at all ages
187 II, 5. 12. 3| rates from cirrhosis per 100,000 men at all ages and
188 II, 5. 12. 3| Europe, i.e. Portugal (38.7/100,000), Italy (35.0), France (
189 II, 5. 12. 3| the England and Wales (3.6/100,000), Ireland (3.4), Norway
190 II, 5. 12. 3| rates between 12 and 15/100,000, and Portugal of around
191 II, 5. 12. 3| and Portugal of around 18/100,000. Similar declines were
192 II, 5. 12. 3| rates were around 10-13/100,000 men in the early 1980s
193 II, 5. 12. 3| early 1980s and around 5/100,000 in 2000-02. Consequently,
194 II, 5. 12. 3| rates remained around 5/100,000 men throughout all the
195 II, 5. 12. 3| 27-34 in 1980-82 to 18-20/100,000 in 2000-02, and even
196 II, 5. 12. 3| rates in 2000-02 were 31-35/100,000 men. Eight European
197 II, 5. 12. 3| from 11.3 in 1980-82 to 15/100,000 in 2000-2002, Finland
198 II, 5. 12. 3| truncated rates reaching 172.2/100,000 men in Hungary and 106.
199 II, 5. 12. 3| middle-aged men (around 75/100,000).~Mortality rates from
200 II, 5. 12. 3| rates in 2000-02 were 22.6/100,000 in Romania, followed
201 II, 5. 12. 3| the lowest ones, below 2/100,000, were in Greece and
202 II, 5. 12. 3| values for women were 53.9/100,000 in Hungary and 44.3
203 II, 5. 12. 3| cirrhosis (around 24-30/100,000).~ ~Table 5.12.2. Age-adjusted (
204 II, 5. 12. 3| rates from cirrhosis per 100,000 women at all ages and
205 II, 5. 12. 7| consumption. Int J Epidemiol 26:100-109.~ ~Corrao G, Aricò S (
206 II, 5. 14. 2| The number and rates (per 100,000 population) of active
207 II, 5. 14. 2| care clinical providers per 100,000 population.~Denominator:
208 II, 5. 15. 2| textual information on 2 100 of them. The RD included
209 II, 5. 15. 3| between 1 in 10 000 and 1 in 100 000. Another 1 000 RD have
210 II, 6. 3. 3| Iceland with 552.45 per 100 000, followed by Denmark
211 II, 6. 3. 3| Denmark with 441.29 per 100 000. Available data show
212 II, 6. 3. 3| levels of up to 200 cases per 100 000 per year in 1995, to
213 II, 6. 3. 3| in 1995, to below 40 per 100 000 per year in 2004. In
214 II, 6. 3. 3| observed in the UK (33.98 per 100 000), followed by Latvia (
215 II, 6. 3. 3| followed by Latvia (30.09 per 100 000) and the lowest in Luxembourg (
216 II, 6. 3. 3| in Luxembourg (0.22 per 100 000), followed by Spain
217 II, 6. 3. 3| Portugal (both with 0.42 per 100 000). However, different
218 II, 6. 3. 3| just under 3.5 to 2.2 per 100 000 per year in 2000, but
219 II, 6. 3. 3| since then reaching 3.1 per 100 000 per year in 2004, mainly
220 II, 6. 3. 3| 1990s (over 60 cases per 100 000 per year in 1995), a
221 II, 6. 3. 3| remained below 10 cases per 100 000 per year, with an overall
222 II, 6. 3. 3| recorded in Latvia (19.21 per 100 000), Lithuania (8.61 per
223 II, 6. 3. 3| 000), Lithuania (8.61 per 100 000) and Estonia (8.24 per
224 II, 6. 3. 3| 000) and Estonia (8.24 per 100 000), with the 25–44 age
225 II, 6. 3. 3| from 6.6 to 2.6 cases per 100 000 per year over the period.
226 II, 6. 3. 3| reported by Iceland (11.24 per 100 000), followed by Latvia (
227 II, 6. 3. 3| followed by Latvia (7.37 per 100 000). Incidence was higher
228 II, 6. 3. 3| increased steadily from 7.0 per 100 000 per year in 2001, to
229 II, 6. 3. 3| year in 2001, to 7.9 per 100 000 per year in 2004, but
230 II, 6. 3. 3| highest incidence rates per 100 000 per year were reported
231 II, 6. 3. 4| have remained below 20 per 100 000 per year since 2001
232 II, 6. 3. 4| Figure 6.A1.1 TB cases per 100,000 selected countries and
233 II, 6. 3. 4| an overall rate of 13 per 100 000 per year, with a countrywide
234 II, 6. 3. 4| notification rate (135 per 100 000 per year in 2005) and
235 II, 6. 3. 4| stable at around one per 100 000 per year. In 2005, a
236 II, 6. 3. 4| highest incidence of 3.36 per 100 000 per year was seen in
237 II, 6. 3. 4| by Iceland with 2.38 per 100 000 per year. In 2005, 746
238 II, 6. 3. 5| between five and six cases per 100 000 per year, but this is
239 II, 6. 3. 5| between one and two cases per 100 000 per year. Good vaccines
240 II, 6. 3. 5| pneumococcal infections (5.83 per 100 000 per year) were reported
241 II, 6. 3. 5| countries. Sweden (15.76 per 100 000) followed by Belgium (
242 II, 6. 3. 5| followed by Belgium (15.45 per 100 000) reported the highest
243 II, 6. 3. 5| over-65 age group (15.3 per 100 000), followed by the under-4
244 II, 6. 3. 5| under-4 age group (14.1 per 100 000), while the incidence
245 II, 6. 3. 5| incidence varied below 2/100 000 per year with stable
246 II, 6. 3. 5| Ireland (with 4.94 per 100 000) and Malta (2.73 per
247 II, 6. 3. 5| 000) and Malta (2.73 per 100 000) reported the highest
248 II, 6. 3. 5| incidence rate, with 1.48 per 100 000, followed by Sweden (
249 II, 6. 3. 5| followed by Sweden (1.31 per 100 000). Hib vaccination is
250 II, 6. 3. 5| the Netherlands (40.17 per 100 000), with Norway reporting
251 II, 6. 3. 5| reporting a rate of 19.10 per 100 000. By contrast, the overall
252 II, 6. 3. 5| rate in the EU was 4.10 per 100 000 per year. Thus pertussis,
253 II, 6. 3. 5| Latvia peaked in 1995 (15 per 100 000 per year) with a second
254 II, 6. 3. 5| second peak in 2000 (11 per 100 000 per year). In Estonia
255 II, 6. 3. 5| an incidence of 0.87 per 100 000.~ ~Tetanus~ ~Tetanus
256 II, 6. 3. 5| were always below 0.2 per 100 000 per year in the EU15
257 II, 6. 3. 5| rates were below 0.35 per 100 000 per year, except for
258 II, 6. 3. 5| incidence was at 0.45 per 100 000 per year in 2000 (nine
259 II, 6. 3. 5| and for Malta with 0.5 per 100 000 per year in 2002 (two
260 II, 6. 3. 5| were in Malta (0.25 per 100 000), followed by Italy (
261 II, 6. 3. 5| followed by Italy (0.11 per 100 000).~ ~
262 II, 6. 3. 5| years from almost 35 per 100 000 per year before 1997
263 II, 6. 3. 5| 1997 to less than 10 per 100 000 per year after 1998 (
264 II, 6. 3. 5| between five and 42 per 100 000 per year. In the other
265 II, 6. 3. 5| fluctuated between one and 10 per 100 000 per year since 2000.~ ~
266 II, 6. 3. 5| incidence in the EU was 0.28 per 100 000 per year and the highest
267 II, 6. 3. 5| and the highest rates per 100 000 were reported by Ireland (
268 II, 6. 3. 5| rates (77.24 and 28.95 per 100 000, respectively). In those
269 II, 6. 3. 5| countries was 17.65 per 100 000 per year.~ ~Rubella~ ~
270 II, 6. 3. 5| overall incidence was 0.51 per 100 000 per year, with Lithuania (
271 II, 6. 3. 5| with Lithuania (3.44 per 100 000) and the Netherlands (
272 II, 6. 3. 5| the Netherlands (2.23 per 100 000) reporting the highest
273 II, 6. 3. 6| Czech Republic (296 per 100 000), followed by the UK (
274 II, 6. 3. 6| followed by the UK (87.95 per 100 000). Campylobacteriosis
275 II, 6. 3. 6| Czech Republic (322 per 100 000), followed by Slovakia (
276 II, 6. 3. 6| by Slovakia (223.67 per 100 000). The highest incidence
277 II, 6. 3. 6| countries. Norway, with 0.87 per 100 000, reported the highest
278 II, 6. 3. 6| followed by the UK (0.79 per 100 000).~ ~Shigellosis~ ~Shigellosis
279 II, 6. 3. 6| incidence rate was 1.82 per 100 000, with the highest incidence
280 II, 6. 3. 6| than five year-old (3.5 per 100 000), representing 10% of
281 II, 6. 3. 6| cases. Lithuania (13.43 per 100 000 total population), followed
282 II, 6. 3. 6| followed by Slovakia (9.51 per 100 000) reported the highest
283 II, 6. 3. 6| Czech Republic (16.72 per 100 000) followed by Sweden (
284 II, 6. 3. 6| followed by Sweden (4.27 per 100 000) reported the highest
285 II, 6. 3. 6| with Lithuania (14.63 per 100 000) followed by Finland (
286 II, 6. 3. 6| followed by Finland (12.2 per 100 000) reporting the highest
287 II, 6. 3. 6| incidence in the EU was 2.23 per 100 000 per year, with children
288 II, 6. 3. 6| highest incidence (30.4 per 100 000 per year).~ ~Listeriosis~ ~
289 II, 6. 3. 6| incidence in 2004 (0.28 per 100 000 per year) was similar
290 II, 6. 3. 6| 2005. Denmark (0.85 per 100 000), followed by Finland (
291 II, 6. 3. 6| followed by Finland (0.69 per 100 000) reported the highest
292 II, 6. 3. 6| under 4 000 cases (0.87 per 100 000)) to 2004 (1 743 cases (
293 II, 6. 3. 6| 2004 (1 743 cases (0.38 per 100 000)). Twenty-six countries
294 II, 6. 3. 6| overall incidence of 0.31 per 100 000. Portugal (1.40 per
295 II, 6. 3. 6| 000. Portugal (1.40 per 100 000), followed by Ireland (
296 II, 6. 3. 6| followed by Ireland (1.29 per 100 000) reported the highest
297 II, 6. 3. 6| highest incidence (0.15 per 100 000).~ ~Cholera~ ~Cholera
298 II, 6. 3. 6| were reported ( 0.01 per 100 000 per year). In 2005,
299 II, 6. 3. 6| countries. Slovakia (9.81 per 100 000) and Latvia (6.29 per
300 II, 6. 3. 6| 000) and Latvia (6.29 per 100 000) are the only countries
301 II, 6. 3. 6| incidences of more than five per 100 000 per year. The highest
302 II, 6. 3. 6| observed in 1995 (1.68 per 100 000 per year), and has shown
303 II, 6. 3. 6| with Lithuania (6.86 per 100 000), followed by Slovakia (
304 II, 6. 3. 6| followed by Slovakia (4.85 per 100 000) reporting the highest
305 II, 6. 3. 6| countries. Estonia (24.28 per 100 000), followed by Iceland (
306 II, 6. 3. 6| followed by Iceland (14.65 per 100 000) reported the highest
307 II, 6. 3. 6| with Ireland (13.75 per 100 000) and the UK (9.26 per
308 II, 6. 3. 6| 000) and the UK (9.26 per 100 000) reporting the highest
309 II, 6. 3. 6| countries. Lithuania (0.44 per 100 000), followed by Slovenia (
310 II, 6. 3. 6| followed by Slovenia (0.30 per 100 000), reported the highest
311 II, 6. 3. 6| countries. Latvia (2.12 per 100 000), followed by Lithuania (
312 II, 6. 3. 6| followed by Lithuania (0.35 per 100 000) reported the highest
313 II, 6. 3. 7| countries. Sweden (2.73 per 100 000), followed by Hungary (
314 II, 6. 3. 7| followed by Hungary (0.86 per 100 000) reported the highest
315 II, 6. 3. 7| between 0.2 and 0.5 cases per 100 000. In 2005, 958 cases
316 II, 6. 3. 7| incidence rates (0.49 per 100 000 and 0.48 per 100 000,
317 II, 6. 3. 7| per 100 000 and 0.48 per 100 000, respectively). This
318 II, 6. 3. 7| from 0.1 to 0.22 cases per 100 000. The lowest number of
319 II, 6. 3. 7| with Estonia (0.82 per 100 000) followed by France (
320 II, 6. 3. 7| followed by France (0.77 per 100 000) reporting the highest
321 II, 6. 3. 7| ranged from 1.45 to 2.27 per 100 000 per year, with a steady
322 II, 6. 4. 4| budget of € 16 million with 100 staff. The Centre’s budget
323 II, 7. 3. 2| is estimated that almost 100 000 lives could be saved
324 II, 7. 3. 2| males (72 injury deaths per 100 000 males) than it is for
325 II, 7. 3. 2| it is for females (35 per 100 000 females). As a result,
326 II, 7. 3. 2| Figure 7.3. Injury deaths per 100 000 by sex and age group,
327 II, 7. 3. 3| discharges due to injuries per 100 000 inhabitants in the EU27
328 II, 7. 3. 4| the EU27 range from 4 per 100 000 inhabitants in Malta
329 II, 7. 3. 4| They range from 0.3 per 100 000 inhabitants in the United
330 II, 7. 3. 4| accidents in the EU27 is 22 per 100,000 residents and is more
331 II, 7. 3. 4| terms every year more than 100 000 EU citizens die from
332 II, 7. 3. 5| rates vary from about 2 per 100 000 people in Cyprus to
333 II, 7. 3. 5| people in Cyprus to 35 per 100 000 in Lithuania (Figure
334 II, 7. 7 | Standardised Death Rate (per 100 000 inhabitants), Suicide
335 II, 7. 7 | Standardised Death Rate (per 100 000 inhabitants), Homicide,
336 II, 9 | Region before age 65, per 100.000 population.~ ~ ~ ~Source:
337 II, 9. 1 | frequently - only 5 to 15 per 100 000 live births – but are
338 II, 9. 1. 1| of developing CP is 60 to 100 times higher in VLBW babies/
339 II, 9. 1. 2| participating from 3% (Germany) to 100% (Norway, Sweden, Finland,
340 II, 9. 3. 1| Work, 2007). Injuries per 100 000 are particularly high
341 II, 9. 3. 1| age group (median 3.9 per 100 000 population), to the
342 II, 9. 3. 1| 25-34 age group (11.2 per 100 000 population), followed
343 II, 9. 3. 1| 35-44 age group (39.2 per 100 000 population) (White and
344 II, 9. 3. 1| from 2.1 to 4.6 to 16.0 per 100 000 population across the
345 II, 9. 3. 1| among men: in Europe, per 100 000 population, Sweden had
346 II, 9. 3. 1| Arthritis . More than 100 million European citizens
347 II, 9. 3. 1| Region before age 65, per 100.000 population.~ ~ ~ ~Source:
348 II, 9. 3. 2| certainly no fewer than 100 000. For smaller countries,
349 II, 9. 3. 2| about 20 maternal deaths per 100 000 live births in the early
350 II, 9. 3. 2| early 1980s to 7 deaths per 100 000. The most significant
351 II, 9. 3. 2| between 140 and 160 per 100 000 in the 1980s. After
352 II, 9. 3. 2| ratio declined to 26 per 100 000 in 2002-2004, still
353 II, 9. 4. 3| population aged 0-14 years [per 100]) shows that Italy is the ‘
354 II, 9. 4. 3| men and 1,318 women per 100 000) and Lithuania (2,219
355 II, 9. 5. 3| the Netherlands (33.5 per 100 000) and Latvia (33.2) (
356 II, 9. 5. 3| the Netherlands (30.8 per 100.000). (WHO HFA-DB, 2006).
357 III, 10. 2. 1| Global Tobacco Epidemic 2008, 100 million people worldwide
358 III, 10. 2. 1| quitting rate by another 50-100% (Fiore et al, 2000). Psychosocial
359 III, 10. 2. 1| of the scale maximum of 100. This increase is mainly
360 III, 10. 2. 1| approximately 90 extra deaths per 100,000 people for men and 60
361 III, 10. 2. 1| people for men and 60 per 100,000 for women (as well as
362 III, 10. 2. 1| estimated that there are between 100 000 and 200 000 former or
363 III, 10. 2. 1| there might be between 100 000 and 200 000 people living
364 III, 10. 2. 1| EU, accounting for 46% to 100%16.Other substances identified
365 III, 10. 2. 1| Public Health Reports, 1985, 100:126-131.~ ~EORG (2003):
366 III, 10. 2. 1| Behavioural Medicine, 25(2):100–104.~ ~European Commission (
367 III, 10. 2. 1| products, EU15, 1995-2002 (1995=100)~ ~Figure 10.2.1.7.6. Average
368 III, 10. 2. 4| tests (i.e., tests with 0-100% probability being a continuum
369 III, 10. 3. 1| radon in dwellings leads to 100 to 1200 extra cases of lung
370 III, 10. 3. 1| UV-B (280-315 nm) and UV-C (100-280 nm). UVR reaching the
371 III, 10. 3. 1| Frequency Fields (RF fields, 100 kHz <f 300 GHz), including
372 III, 10. 3. 1| Fields, (IF fields, 300 Hz <f 100 kHz), experimental and epidemiological
373 III, 10. 3. 4| people reported killed, 100 people reported affected,
374 III, 10. 3. 4| Estimated total damages of a 100-year flood are projected
375 III, 10. 3. 4| 10 or more killed and/or 100 or more affected are included
376 III, 10. 4. 1| considered to be responsible for 100 000 deaths and 750 000 life
377 III, 10. 4. 2| Campylobacteriosis~51.6 per 100 000~Increasing (7.8% in
378 III, 10. 4. 2| water~Salmonellosis~35.0 per 100 000~Decreasing in eggs over
379 III, 10. 4. 2| incidence rate of 51.6 cases per 100,000 people and to a total
380 III, 10. 4. 2| significant risk to human health (100 bacteria/g). However, in
381 III, 10. 4. 2| findings and samples over the 100 cfu/g limit were made indicating
382 III, 10. 4. 2| Netherlands to PAHs, ~about 100-200 ng per~person per day ~
383 III, 10. 4. 2| Ecotoxicol Environ Saf Vol. 63: 100-7~ ~RIVM (2006):Our Food,
384 III, 10. 4. 3| In Western Europea almost 100% of the population have
385 III, 10. 4. 3| age fell from 70.0 (per 100 000) to 21.6 in the Commonwealth
386 III, 10. 4. 3| particularly in Asia with over 100 million people affected.
387 III, 10. 4. 3| level is in the range 1/100-1/1000 (Vahter et al, 2006).
388 III, 10. 4. 3| At 50 μg/l the risk 1/100 which is 100 times higher
389 III, 10. 4. 3| the risk 1/100 which is 100 times higher than for any
390 III, 10. 4. 3| In Western Europe, almost 100% of the population has had
391 III, 10. 5. 2| the stroke incidence per 100.000 citizens is much higher
392 III, 10. 5. 3| is high, probably about 100%. On the other hand, in
393 III, 10. 5. 3| incidence rate of app. 1800 per 100,000 is reported for the
394 III, 10. 5. 3| average rates of app. 60 per 100,000.~ ~Table 10.5.3.2. Number
395 III, 10. 5. 3| compensation schemes, the rate per 100,000 insured people varied
396 III, 10. 5. 3| serious accidents at work per 100 thousand persons in employment
397 III, 10. 5. 3| economic activity (rate per 100 000 workers)~ ~Perception
398 III, 10. 5. 3| occupational accidents per 100.000 workers in the EU27.~
399 III, 10. 5. 3| Policy Implications (pp. 73-100). Oxford: Oxford University
400 IV, 11. 1. 3| capita increased by almost 100% between 1990 and 2004,
401 IV, 11. 1. 6| fee-for-service for private work.~100% by salary for public patients;
402 IV, 11. 1. 6| fee-for-service for private patients.~100% by salary for public patients,
403 IV, 11. 1. 6| fee-for-service for private patients.~100% by fee-for-service.~Estonia~
404 IV, 11. 1. 6| Fee-for-service.~Germany~100% by fee-for-service.~100%
405 IV, 11. 1. 6| 100% by fee-for-service.~100% by fee-for-service.~Salary.
406 IV, 11. 1. 6| Fee-for-service for private patients.~100% by salary.~Greece~Salary
407 IV, 11. 1. 6| payments for preventive care).~100% by fee-for-service.~ ~100%
408 IV, 11. 1. 6| 100% by fee-for-service.~ ~100% by salary.~ ~Fee-for-service.~ ~
409 IV, 11. 1. 6| and 15% from capitation).~100% by salary.~ ~100% by salary.~ ~
410 IV, 11. 1. 6| capitation).~100% by salary.~ ~100% by salary.~ ~Mainly by
411 IV, 11. 1. 6| Sweden~Salary~Salary~100% by salary~100% by salary~
412 IV, 11. 1. 6| Salary~Salary~100% by salary~100% by salary~Switzerland~96%
413 IV, 11. 2. 1| hospitals declined from 3.82 per 100,000 population in 1990 to
414 IV, 11. 2. 1| Number of hospital beds per 100,000 population, 2007 or
415 IV, 11. 2. 1| with over 25 admissions per 100 population. Moreover, there
416 IV, 11. 2. 1| of psychiatric beds per 100,000 population, 1996-2005 (
417 IV, 11. 3. 1| almost 500 physicians per 100,000 population. High density
418 IV, 11. 3. 1| dentists, and pharmacists per 100,000 population, 2006 or
419 IV, 11. 3. 1| Netherlands (1,454 nurses per 100,000 population), with high
420 IV, 11. 3. 1| also in Belgium (1,341 per 100,000), and in particularly
421 IV, 11. 3. 1| Norway (over 1,500 nurses per 100,000).~ ~Educational paths
422 IV, 11. 6. 2| Twenty years ago there were 100 funds, while currently there
423 IV, 11. 6. 2| maximums, ranging from about €100 in Sweden to about €600
424 IV, 11. 6. 4| insurance funds, respectively) 100% of funds are redistributed;
425 IV, 11. 6. 4| current level of 60% to 100% by 2009 (Thomson, Foubister
426 IV, 11. 6. 4| Insurance (RIZIV/INAMI)~100 competitive sickness funds~
427 IV, 11. 6. 4| all OECD countries cover 100% or almost 100% of the population
428 IV, 11. 6. 4| countries cover 100% or almost 100% of the population to statutory
429 IV, 12. 2 | quitting rate by another 50-100%. Psychosocial interventions
430 IV, 12. 10 | Ministerial Decisions 34258 and 100 (published in 2002) concerning
431 IV, 12. 10 | The 2004 law has set up 100 objectives in the various
432 IV, 12. 10 | sexual crime (all ages), n/100,000 inhabitants~ ~Reported
433 IV, 12. 10 | rapes of persons 15 years, n/100,000 inhabitants~Domain of
434 IV, 13. 2. 3| Cardiovascular diseases, all cancers~100,000-300,000~5 dietary factors
435 IV, 13. 2. 3| alcohol-dependency~ ~ ~ ~ ~30,000-100,000~Excess of trans fatty
436 IV, 13. 6. 2| statistics on doctors per 100,000 population, within which
|
|
| |
